Pharmaceutical preparation for chronic pelvic inflammatory disease and preparation method thereof

Abstract

The invention belongs to the technical field of pharmaceutical preparations, and discloses a pharmaceutical preparation for chronic pelvic inflammation. The pharmaceutical preparation for the chronicpelvic inflammation is prepared from the following raw materials: 400g of rhizoma smilacis glabrae, 200g of radix salviae miltiorrhizae, 200g of spica prunellae, 250g of herba taraxaci, 2000g of semenplantaginis, 150g of rhizoma dioscoreae hypoglaucae, 150g of cortex eucommiae, 50g of radix notoginseng, and 80g of rhizoma chuanxiong. Animal experiments indicate that the pharmaceutical preparationdisclosed by the invention has good effects and smaller toxic and side effects.

Description

technical field [0001] The invention belongs to the technical field of medicine preparation, in particular to a medicine preparation for chronic pelvic inflammatory disease and a preparation method thereof. Background technique [0002] Pelvic inflammatory disease refers to the inflammation of female pelvic reproductive organs, connective tissue around the uterus and pelvic peritoneum. There are two types of clinical manifestations of pelvic inflammatory disease: acute and chronic. The symptoms of chronic pelvic inflammatory disease are lower abdomen swelling, pain and lumbosacral pain, which are often aggravated after fatigue, sexual intercourse and before and after menstruation. For a long time, there may be symptoms of neurasthenia such as lack of energy, general discomfort, and insomnia. The incidence rate of the disease tends to increase. The causes of the disease are complicated, the condition is stubborn, and it is easy to relapse. The symptoms are good and bad, whic...

AI Technical Summary

Problems solved by technology

[0004] Puling Penyankang Granules is a pharmaceutical preparation independently developed by the applicant with a drug batch number. It has a good therapeutic effect on chronic pelvic inflammatory disease. For this product, the applicant has also applied for a patent technology on Puling Penyankang Granules. For example, "2006101525479, a drug for treating chronic pelvic inflammatory disease and its preparation method", which protects Puling Penyankang granules on sale; the later patent "2015103361326, a pharmaceutical preparation of Puling Penyankang for pelvic inflammatory disease and its detection method" has been improved on the basis of the known Puling Penyankang Granules, including 40 parts of Dandelion, 35 parts of Smilax, 35 parts of Bangui, 35 parts of Pueraria, 30 parts of Lily, 30 parts of Cyperus, 30 parts of Radix Paeoniae Rubra, 25 parts of Patrinia, 25 parts of Phellodendron Phellodendri, 25 parts of Draconis japonicus, 25 parts of Cinnamon, 20 parts of Trigonium, 20 parts of Puhuang, 20 parts of Citrus aurantium, 17 parts of Myrrh, 17 parts of Platycodon grandiflorum, 15 parts of Angelica dahurica 10 parts, 10 parts of madder, 10 parts of poria cocos, 10 parts of forsythia, 10 parts of hundred parts, 5 parts of honeysuckle, its effect is better than known medicines, but there are many types of raw materials, unclear mechanism of action, high defects such as cost